Surgery – Blood drawn and replaced or treated and returned to body
Patent
1992-02-28
1994-09-06
Hafer, Robert A.
Surgery
Blood drawn and replaced or treated and returned to body
424 5, A61K 4700
Patent
active
053443934
ABSTRACT:
A method for facilitating autologous blood use by a patient facing a loss of blood, comprising the steps of removing and preferably storing a portion of the patient's blood, intravenously administering a biocompatible liquid in sufficient quantity to substantially maintain the patient's hemodynamic stability, wherein the liquid comprises an effective oxygen-delivery enhancing amount of a biocompatible synthetic oxygen carrier, after which the patient undergoes a loss of blood, and then readministering blood to the patient, preferably the stored blood. In one embodiment, the biocompatible liquid further comprises a hemodiluent and the hemodiluent is administered separately from the oxygen carrier.
REFERENCES:
patent: 3482575 (1969-12-01), Claffe et al.
patent: 3975512 (1976-08-01), Long
patent: 4073879 (1978-02-01), Long
patent: 4275726 (1981-06-01), Schael
patent: 4301144 (1981-11-01), Iwashita et al.
patent: 4473494 (1984-09-01), Tye
patent: 4526715 (1985-07-01), Kothe et al.
patent: 4600531 (1986-06-01), Walder
patent: 4698387 (1987-10-01), Schmidt et al.
patent: 4777244 (1988-10-01), Bonhard et al.
patent: 4861867 (1989-08-01), Estep
patent: 4911929 (1990-03-01), Farmer et al.
patent: 4927623 (1990-05-01), Long, Jr.
patent: 4963130 (1990-10-01), Osterholm
patent: 4981691 (1991-01-01), Osterholm et al.
patent: 4987154 (1991-01-01), Long, Jr.
patent: 5080885 (1992-01-01), Long, Jr.
patent: 5130230 (1992-07-01), Segall et al.
Homer, L. D. et al., Microvascular Research 22: 308-323 (1981).
Messmer, K. et al., Res. Exp. Med. 159: 152-166 (1973).
Messmer, K. et al., Eur. Surg. Res. 18: 254-263 (1986).
Riess, Jean G., Artificial Organs 8(1): 44-56 (1984).
Riess, J. G. et al., International Symposium on Blood Substitutes, Montreal (1987).
Winslow, Robert, International J. of Clinical Monitoring and Computing 2: 81-93 (1985).
Zauder, Howard, Hemorrhagic Disorders 8(3): 471-481 (1990).
Zuck, T. et al., Vox Sang 58: 234-253 (1990).
K. Fukushima et al., "Clinical experience of hemodilution with Fluosol-DA", Jpn. J Anesthesiol, vol. 30, No. 7, 1981, pp. 741-745.
C. L. Sheffiedl et al., "Preparation and in vivo evaluation of two bovine hemoglobin-based plasma expanders", Biotechnol. Appl. Biochem., vol. 12, No. 6, 1990, pp. 630-642.
J. G. Riess, "Overview of progress in the fluorocarbon approach to in vivo oxygen delivery", Biomater. Artif. Cells Immobilization Biotechnol., vol. 20, No. 2-4, 1992, pp. 183-202.
Fukushima, et al. "Clinical Experience of Autologous Blood Transfusion By Hemodilution With Fluosol-DA"Japanese J. Anesthesiology, 30: pp. 741-745 Translation.
Gould, S. A. et al., JAMA 314: 1653-1656 (1986).
Mercuriali, et al., Autologous Blood 2-30 (1991).
Reiss, J. G., Vox Sang 61: 225-239 (1991).
Stehling, et al., Transfusion 31: 857-868 (1991).
Faithfull, N. S. et al., Microvascular Research 33: 183-193 (1987).
Faithfull, N. S. et al., J. of Critical Care 3(1): 14-18 (1988).
Federspiel, W. et al., Microvascular Research 32: 164-189 (1986).
Giordano, G. F. et al., Transfusion 31(6):509-512 (1991).
Greenwalt, et al., JAMA 260(18): 2700-2703 (1988).
Gutierrez, G., Respiration Physiology 63: 79-96 (1986).
Faithfull Nicholas S.
Keipert Peter E.
Riess Jean G.
Roth Duane J.
Zuck Thomas F.
Alliance Pharmaceutical Corp.
Hafer Robert A.
Rimell Sam
LandOfFree
Use of synthetic oxygen carriers to facilitate oxygen delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of synthetic oxygen carriers to facilitate oxygen delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of synthetic oxygen carriers to facilitate oxygen delivery will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1326646